Relora is the registered trademark for a natural proprietary blend of a patented (Patent No. US 6,582,735) extract from the bark of Magnolia officinalis and a proprietary extract from the bark of Phellodendron amurense. Both plant materials have played a major role in traditional Chinese medicine for over 1,500 years. The particular proprietary fractions and the resulting blend are the results of Next Pharmaceuticals’ screenings of more than twenty different plants from around the world in an effort to develop a safe and effective natural ingredient for cortisol control and stress-related conditions. Following bioassay-directed fractionation, animal studies validated for benzodiazepine-like pharmacology, and three toxicology studies, Next conducted two human studies and one clinical trial prior to embarking on a placebo-controlled clinical trial.

Watch Relora Video to find out more information click here